PROCEPT BioRobotics Corp. Announces Investor Event at 2023 AUA Annual Meeting in Chicago
REDWOOD CITY, Calif., March 30, 2023 (GLOBE NEWSWIRE) -- PROCEPT® BioRobotics Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, announced today it will host an in-person investor event on Friday, April 28, 2023, in Chicago at the American Urological Association Annual Meeting from 8:00am to 9:30am Central Time. This meeting will be held at the Gwen Hotel and will include remarks from PROCEPT BioRobotics’ executive team, in addition to a surgeon panel on the benefits of Aquablation therapy.
Members of PROCEPT BioRobotics’ management team presenting include:
Clinical perspectives will also be provided by the following physicians:
A live webcast of the event, as well as an achived recording, will be available on the “Investors” section of the Company’s website at https://ir.procept-biorobotics.com/. The webcast will be archived and available for replay for at least 90 days after the event.
About PROCEPT BioRobotics Corporation
All surgical treatments have inherent and associated side effects. For a list of potential side effects visit https://aquablation.com/safety-information/.
Registration Counters Open
Continental Breakfast Served
Keynote Presentation by Avaya